Status:

COMPLETED

Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts

Lead Sponsor:

University of Michigan

Conditions:

Asthma

Eligibility:

All Genders

18-85 years

Brief Summary

This study will utilize University of Michigan EMR data to form a retrospective cohort of severe asthma patients on biologic therapies for asthma with computed tomography (CT) imaging and known outcom...

Detailed Description

The two arms for this study represent the two cohorts: the University of Michigan cohort, and the National Jewish Health cohort. The cohorts were split into arms, as the National Jewish Health cohort ...

Eligibility Criteria

Inclusion

  • Asthma diagnosis defined as a positive methacholine test, supportive PFTs, or clinician diagnosis with appropriate supporting clinical context
  • Prescribed and taking an FDA-approved biologic medication for severe asthma (mepolizumab, benralizumab, reslizumab, omalizumab, or dupilumab)
  • Chest computerized tomography (CT) images taken for any clinical purpose

Exclusion

  • 10-year history of smoking
  • Evidence of emphysema on CT imaging
  • Severe bronchiectasis secondary to other causes (subjects with scattered bronchiectasis secondary to severe asthma will not excluded)
  • Lack of accessible adequate follow-up information (4 or more months from drug initiation with clear documentation of response) will be excluded from final analysis due to inability to assess response but will be included in the initial cluster identification

Key Trial Info

Start Date :

January 15 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 31 2024

Estimated Enrollment :

233 Patients enrolled

Trial Details

Trial ID

NCT06922760

Start Date

January 15 2021

End Date

July 31 2024

Last Update

November 18 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

National Jewish Health

Denver, Colorado, United States, 80206

2

University of Michigan

Ann Arbor, Michigan, United States, 48109

Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts | DecenTrialz